Search by Drug Name or NDC

    NDC 00254-1016-36 POSACONAZOLE 40 mg/mL Details

    POSACONAZOLE 40 mg/mL

    POSACONAZOLE is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Par Pharmaceutical Inc.. The primary component is POSACONAZOLE.

    Product Information

    NDC 00254-1016
    Product ID 0254-1016_120c8d44-0e83-4fe7-9af7-c87efb13567a
    Associated GPIs
    GCN Sequence Number 060365
    GCN Sequence Number Description posaconazole ORAL SUSP 200 MG/5ML ORAL
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 26502
    HICL Sequence Number 033461
    HICL Sequence Number Description POSACONAZOLE
    Brand/Generic Generic
    Proprietary Name POSACONAZOLE
    Proprietary Name Suffix n/a
    Non-Proprietary Name posaconazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/mL
    Substance Name POSACONAZOLE
    Labeler Name Par Pharmaceutical Inc.
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS]
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA022003
    Listing Certified Through 2024-12-31

    Package

    NDC 00254-1016-36 (00254101636)

    NDC Package Code 0254-1016-36
    Billing NDC 00254101636
    Package 1 BOTTLE, GLASS in 1 CARTON (0254-1016-36) / 105 mL in 1 BOTTLE, GLASS
    Marketing Start Date 2023-03-29
    NDC Exclude Flag N
    Pricing Information N/A